Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:

  • a review of the information gathered on the shortage issue, and
  • a thorough discussion on its potential impact and next steps.

Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
TEVA-SUCRALFATE TEVA CANADA LIMITED Actual shortage 1G Updated Report 2022-08-18 162303
FERRLECIT SANOFI-AVENTIS CANADA INC Actual shortage 12.5MG Updated Report 2022-08-18 164234
AVAPRO SANOFI-AVENTIS CANADA INC Actual shortage 300MG Updated Report 2022-08-18 165911
GLUCOPHAGE SANOFI-AVENTIS CANADA INC Actual shortage 500MG Updated Report 2022-08-18 165003
TEVA-SPIRONOLACTONE TEVA CANADA LIMITED Anticipated shortage 100MG New Report 2022-08-18 167255
TEVA-NITROFURANTOIN TEVA CANADA LIMITED Anticipated shortage 50MG New Report 2022-08-18 167251
PLAVIX SANOFI-AVENTIS CANADA INC Actual shortage 75MG Updated Report 2022-08-18 165000
TEVA-MIRTAZAPINE TEVA CANADA LIMITED Anticipated shortage 30MG New Report 2022-08-18 167246
TEVA-GABAPENTIN TEVA CANADA LIMITED Anticipated shortage 100MG New Report 2022-08-18 167241
CALCIMAR SANOFI-AVENTIS CANADA INC Anticipated shortage 200UNIT Updated Report 2022-08-18 167224

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
PMS-CELECOXIB PHARMASCIENCE INC Discontinued 200MG New Report 2022-08-18 166951
PMS-CELECOXIB PHARMASCIENCE INC Discontinued 200MG New Report 2022-08-18 166948
PMS-CELECOXIB PHARMASCIENCE INC Discontinued 200MG New Report 2022-08-18 166945
PMS-CELECOXIB PHARMASCIENCE INC To be discontinued 200MG New Report 2022-08-18 166939
ZEPATIER MERCK CANADA INC Discontinued 100MG 50MG Updated Report 2022-08-17 158741